# Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2)

> **NCT02369848** · NA · COMPLETED · sponsor: **Shockwave Medical, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** Shockwave Lithoplasty System

## Key facts

- **NCT ID:** NCT02369848
- **Lead sponsor:** Shockwave Medical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2015-12
- **Final completion:** 2016-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02369848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02369848, "Shockwave Lithoplasty DISRUPT Trial for PAD (DISRUPT PAD 2)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02369848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
